The PE Ratio as of June 2026 (TTM) for BeOne Medicines Ltd. Class A (688235.SS) is 94.48

According to BeOne Medicines Ltd. Class A’s latest financial reports and current stock price. The company's current PE Ratio is 94.48. This represents a change of 36.38% compared to the average of 69.28 of the last 4 quarters.

BeOne Medicines Ltd. Class A (688235.SS) Historical PE Ratio (quarterly & annually)

How has 688235.SS PE Ratio performed in the past?

The mean historical PE Ratio of BeOne Medicines Ltd. Class A over the last ten years is 15.45. The current 94.48 PE Ratio has changed 61.06% with respect to the historical average. Over the past ten years (40 quarters), 688235.SS's PE Ratio was at its highest in in the March 2025 quarter at 720.10. The PE Ratio was at its lowest in in the June 2016 quarter at -8.26.

BeOne Medicines Ltd. Class A (688235.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BeOne Medicines Ltd. Class A PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BeOne Medicines Ltd. Class A (688235.SS) Average PE Ratio

How has 688235.SS PE Ratio performed in the past?

The current PE Ratio of BeOne Medicines Ltd. Class A (688235.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BeOne Medicines Ltd. Class A (688235.SS) PE Ratio vs. Peers

How is 688235.SS’s PE Ratio compared to its peers?

BeOne Medicines Ltd. Class A’s PE Ratio is greater than WuXi AppTec Co., Ltd. (14.49), greater than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (23.36), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (-96.08), greater than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (-90.99), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (11.73), greater than RemeGen Co Ltd (49.37), greater than Shanghai Junshi Biosciences Co., Ltd. (-47.64), greater than Nanjing Vazyme Biotech Co., Ltd. (-398.86), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (49.15), greater than Sinocelltech Group Limited (-18.68),

Build a custom stock screener for BeOne Medicines Ltd. Class A (688235.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines Ltd. Class A using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BeOne Medicines Ltd. Class A (688235.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BeOne Medicines Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.